N. Murray

Randomized dose comparison phase II study of the oral transforming growth factor-beta (TGF-ß) receptor I kinase inhibitor LY2157299 monohydrate (LY) in patients with advanced hepatocellular carcinoma (HCC).

G. Giannelli, E. Raymond, A. Santoro, 2013 .

Melanoma-derived interleukin 6 inhibits in vivo melanoma growth.

N. Murray, C. Armstrong, J. Ansel, 1994, The Journal of investigative dermatology.

Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells.

I. Song, N. Murray, C. Armstrong, 1996, Cancer research.